Hepatology (Baltimore, Md.)
Impact of newer antihyperglycemic agents on hepatic complications: A systematic review and meta-analysis of data from 5.3 million patients with type 2 diabetes mellitus.
Jiwon Yang, Yeongseok Hwang, Jin-Sung Ju, Seungbong Han, Jihyun An, Ju Hyun Shim
Published: 202610.1097/HEP.0000000000001695
Abstract
BACKGROUND AIMS: Type 2 diabetes mellitus (T2DM) is a recognized modifiable risk factor for hepatocellular carcinoma (HCC) and liver-related mortality. The effects of newer antidiabetic agents-including glucagon-like peptide-1 receptor agonists (GLP-…
Preview only. Read the full abstract at the source